Research ArticleDrug Discovery and Translational Medicine
An Engineered Human Follistatin Variant: Insights into the Pharmacokinetic and Pharmocodynamic Relationships of a Novel Molecule with Broad Therapeutic Potential
Amita Datta-Mannan, Benjamin Yaden, Venkatesh Krishnan, Bryan E. Jones and Johnny E. Croy
Journal of Pharmacology and Experimental Therapeutics March 2013, 344 (3) 616-623; DOI: https://doi.org/10.1124/jpet.112.201491
Amita Datta-Mannan
Departments of Drug Disposition Development/Commercialization (A.D.-M.) Biotechnology Discovery Research (J.E.C.), and Musculoskeletal Research (B.Y., V.K.), Lilly Research Laboratories, Indianapolis, Indiana; Biotechnology Discovery Research (B.E.J.), Applied Molecular Evolution, San Diego, California; and Department of Biology, School of Science, Center for Regenerative Biology and Medicine, Indiana University–Purdue University, Indianapolis, Indiana (B.Y., V.K.)
Benjamin Yaden
Departments of Drug Disposition Development/Commercialization (A.D.-M.) Biotechnology Discovery Research (J.E.C.), and Musculoskeletal Research (B.Y., V.K.), Lilly Research Laboratories, Indianapolis, Indiana; Biotechnology Discovery Research (B.E.J.), Applied Molecular Evolution, San Diego, California; and Department of Biology, School of Science, Center for Regenerative Biology and Medicine, Indiana University–Purdue University, Indianapolis, Indiana (B.Y., V.K.)
Venkatesh Krishnan
Departments of Drug Disposition Development/Commercialization (A.D.-M.) Biotechnology Discovery Research (J.E.C.), and Musculoskeletal Research (B.Y., V.K.), Lilly Research Laboratories, Indianapolis, Indiana; Biotechnology Discovery Research (B.E.J.), Applied Molecular Evolution, San Diego, California; and Department of Biology, School of Science, Center for Regenerative Biology and Medicine, Indiana University–Purdue University, Indianapolis, Indiana (B.Y., V.K.)
Bryan E. Jones
Departments of Drug Disposition Development/Commercialization (A.D.-M.) Biotechnology Discovery Research (J.E.C.), and Musculoskeletal Research (B.Y., V.K.), Lilly Research Laboratories, Indianapolis, Indiana; Biotechnology Discovery Research (B.E.J.), Applied Molecular Evolution, San Diego, California; and Department of Biology, School of Science, Center for Regenerative Biology and Medicine, Indiana University–Purdue University, Indianapolis, Indiana (B.Y., V.K.)
Johnny E. Croy
Departments of Drug Disposition Development/Commercialization (A.D.-M.) Biotechnology Discovery Research (J.E.C.), and Musculoskeletal Research (B.Y., V.K.), Lilly Research Laboratories, Indianapolis, Indiana; Biotechnology Discovery Research (B.E.J.), Applied Molecular Evolution, San Diego, California; and Department of Biology, School of Science, Center for Regenerative Biology and Medicine, Indiana University–Purdue University, Indianapolis, Indiana (B.Y., V.K.)

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleDrug Discovery and Translational Medicine
PK and PD of Novel Engineered Follistatin
Amita Datta-Mannan, Benjamin Yaden, Venkatesh Krishnan, Bryan E. Jones and Johnny E. Croy
Journal of Pharmacology and Experimental Therapeutics March 1, 2013, 344 (3) 616-623; DOI: https://doi.org/10.1124/jpet.112.201491
Research ArticleDrug Discovery and Translational Medicine
PK and PD of Novel Engineered Follistatin
Amita Datta-Mannan, Benjamin Yaden, Venkatesh Krishnan, Bryan E. Jones and Johnny E. Croy
Journal of Pharmacology and Experimental Therapeutics March 1, 2013, 344 (3) 616-623; DOI: https://doi.org/10.1124/jpet.112.201491
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement